The government on Wednesday asked all state drug controllers to ensure availability of essential medicines and medical devices required in the treatment of COVID-19.
In a meeting with thestate drug controllers,Union Pharma Secretary P D Vaghela asked them "to provide all support to manufacturing units with the help of local administration and concerned authorities by regular interaction so that there is no shortage of medicines and medical devices".
They were also requested to ensure the utilisation of manufacturing capacity to full extent so that sufficient stocks without any hindrance can be made available at all levels, the ministry of chemicals and fertilizers said in a release.
They were instructed to ensure that hoarding and price escalation of drugs and medical devices do not happen and to initiate action in such cases, the release said.
The pharma secretary also asked them to monitor availability of the hydroxychloroquine, azythromycin and paracetamol formulations, the release said.
The state drug controllers were also asked to monitor the list ofessential drugs circulated by the Ministry of Health & Family Welfare on regular basis and to provide the data, it added.
They were asked to provide information of drugs and devices manufacturing units in their states, the release said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
